RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Private Placement Transcode Therapeutics Inc. has entered into a securities purchase agreement to raise approximately $8 million through a private placement of shares and warrants, aiming to meet Nasdaq's minimum stockholders equity requirement after previously being notified of non-compliance.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC